Showing results (571-580 of 1,018) with videos related to

Sort By:
Pageof 102
Cancer Research Communications|August 5, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants With Metastatic Solid TumorsFunda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, et al.
Cancer Research Communications|August 20, 2025
Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal CancerRona Yaeger, Jean-François Martini, Lincoln Pasquina, et al.
Cancer Research Communications|September 25, 2025
Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter StudyKohei Shitara, Motohiro Tamiya, Kyoichi Okishio, et al.
Cancer Research Communications|August 6, 2025
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted TherapiesHyun Jung Lee, Roman Gulati, Erolcan Sayar, et al.
Cancer Research Communications|August 11, 2025
Selective Depletion of Cancer Cells with Extrachromosomal DNA via Lentiviral InfectionEunhee Yi, Amit D Gujar, Dacheng Zhao, et al.
Cancer Research Communications|July 31, 2025
PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer PatientsEshwari Dathathri, Fikri Abali, Michiel Stevens, et al.
Cancer Research Communications|July 31, 2025
GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor ProfilingHassan Ghani, Anthony Helmstetter, Jennifer R Ribeiro, et al.
Cancer Research Communications|July 7, 2025
Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non-Small Cell Lung Cancer PatientsLauren Polyakov, Angelina Lim, Alexandra Meyer, et al.
Cancer Research Communications|December 18, 2025
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell LinesAlexander Zheleznyak, Dhanusha Duraiyan, Prasanth Thunuguntla, et al.
Cancer Research Communications|December 9, 2025
OPG-producing B Cells and RANKL-expressing T cells define immune signatures predictive of bone metastases in breast cancerAna Carolina Monteiro, Diego D Garcia, Ana Paula A Fontão, et al.
Pageof 102